
KalVista Pharmaceuticals Inc (KALV)
NASDAQ
Fin d'année 30 Avril 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -40.825 | -33.019 | -23.191 | -27.643 | -25.371 | -34.604 | -48.004 | -60.507 |
Return on Equity (%) | -46.14 | -53.96 | -33.577 | -32.263 | -27.127 | -37.233 | -53.685 | -68.902 |
Return on Invested Capital (%) | -53.992 | -63.987 | -48.413 | -44.866 | -34.016 | -43.727 | -64.121 | -76.551 |
Operating Margin (%) | -1236.902 | -188.289 | -128.307 | -230.418 | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | -1236.902 | -188.289 | -129.075 | -229.441 | N/A | N/A | N/A | N/A |
Book Value Per Share | 1.534 | 1.267 | 3.457 | 2.933 | 7.321 | 5.25 | 3.592 | 3.906 |
Earnings Per Share | -0.911 | -0.735 | -0.744 | -1.02 | -1.316 | -2.335 | -2.072 | -2.394 |
Cash Per Share | 1.516 | 2.374 | 1.144 | 0.553 | 1.44 | 0.872 | 1.254 | 0.601 |
Working Capital Per Share | 1.529 | 1.682 | 3.484 | 2.836 | 7.244 | 5.164 | 3.508 | 3.836 |
Operating Profit Per Share | 0.074 | 0.39 | 0.576 | 0.444 | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.911 | -0.735 | -0.739 | -1.024 | -1.316 | -2.335 | -2.072 | -2.394 |
EBITDA Per Share | -0.911 | -0.735 | -0.739 | -1.024 | -1.316 | -2.335 | -2.072 | -2.394 |
Free Cash Flow Per Share | -0.909 | -0.677 | -0.719 | -1.03 | -1.329 | -2.325 | -2.062 | 1.168 |
Fin d'année 30 Avril 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 9,71M | 10,8M | 17,28M | 17,85M | 24,42M | 24,55M | N/A | N/A |
Fin d'année 30 Avril 2024 | Jan 2023 | Avr 2023 | Juil 2023 | Oct 2023 | Jan 2024 | Avr 2024 | Juil 2024 | Oct 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 34,13M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 592,52M |
Ratio cours/bénéfice | -4,84 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 19,28 |
Ratio prix/valeur comptable | 2,97 |
Rendement de dividende | - |
Actions en circulation | 49,42M |
Volume moyen (1 semaine) | 684,09k |
Volume moyen (1 mois) | 580,65k |
Variation sur 52 semaines | -11,47% |
Plus haut sur 52 semaines | 15,50 |
Plus bas sur 52 semaines | 7,30 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales